FDA Delays Ruling on Generic Drug Safety Regulations


The New York Times reports that the Food and Drug Administration has delayed until 2017 a decision on whether or not to require the manufacturers of generic medications to warn patients of the potentially dangerous side-effects of their drugs. The argument made by the manufacturers of generic pharmaceuticals is that such labels would only confuse consumers who may have seen different warnings on the brand-name packaging of the same drugs. The FDA stated that delaying this rule would allow generic drug manufacturers to independently update their safety warnings to match those provided by brand-name alternatives according to statnews.com. However, this delay could very well continue the trend of poorly informed patients suffering injury or harm due to lack of proper warnings.

The Dallas dangerous drug attorneys at Polewski & Associates understand how difficult it can be to fully understand the risks posed by certain medications. This issue is made more dangerous when generic drug companies are not required to disclose all potential side-effects of a medication – particularly as generic prescriptions become more and more common due to insurance regulations. Even when not required by law to warn patients of harm, a drug company may be liable for injury caused by their product. Our attorneys are prepared to investigate your case, identify the liable party, and help you get the compensation your injuries demand.

If you have been injured or a loved one has been killed by a dangerous medication, please contact Polewski & Associates online or by calling our DeSoto office at 972-230-6200 to schedule a free consultation. We proudly serve men and women living in Dallas, North Texas, and throughout Arkansas.

polewski logo1 WHITE

Ask John

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

*All indicated fields must be completed.
Please include non-medical questions and correspondence only.

association logo 1 0
association logo 2 0
association logo 3 0
associationLogoNew 0
tbls logo rgb R tag 0

Accessibility Toolbar